During the past decade, Nephrology and Internal Medicine of Anderson conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 2 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Nephrology and Internal Medicine of Anderson" #1 collaborator was "Hospira, now a wholly owned subsidiary of Pfizer" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Nephrology and Internal Medicine of Anderson" are "Chronic Kidney Disease" (1 trials), "Chronic Renal Failure" (1 trials) and "Chronic Renal Failure Requiring Hemodialysis" (1 trials). Many other conditions were trialed in "Nephrology and Internal Medicine of Anderson" in a lesser frequency.

Most popular intervention types in "Nephrology and Internal Medicine of Anderson" are "Biological" (2 trials). Other intervention types were less common.

The name of intervention was led by "Epoetin Hospira" (2 trials) and "Epogen (Amgen)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Nephrology and Internal Medicine of Anderson" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Nephrology and Internal Medicine of Anderson". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Nephrology and Internal Medicine of Anderson, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Nephrology and Internal Medicine of Anderson, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".